Bio-Rad Laboratories, Inc. (BIO)
381.07
+1.04
(+0.27%)
USD |
NYSE |
Aug 24, 16:00
381.07
0.00 (0.00%)
After-Hours: 20:00
Bio-Rad Laboratories Shareholders Equity (Quarterly) : 7.174B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.174B |
| March 31, 2026 | 6.851B |
| December 31, 2025 | 7.454B |
| September 30, 2025 | 6.737B |
| June 30, 2025 | 7.129B |
| March 31, 2025 | 6.679B |
| December 31, 2024 | 6.569B |
| September 30, 2024 | 7.488B |
| June 30, 2024 | 6.779B |
| March 31, 2024 | 9.051B |
| December 31, 2023 | 8.741B |
| September 30, 2023 | 8.416B |
| June 30, 2023 | 8.447B |
| March 31, 2023 | 9.764B |
| December 31, 2022 | 9.615B |
| September 30, 2022 | 8.454B |
| June 30, 2022 | 8.923B |
| March 31, 2022 | 10.18B |
| December 31, 2021 | 13.69B |
| September 30, 2021 | 15.33B |
| June 30, 2021 | 11.59B |
| March 31, 2021 | 10.61B |
| December 31, 2020 | 9.880B |
| September 30, 2020 | 8.825B |
| June 30, 2020 | 7.353B |
| Date | Value |
|---|---|
| March 31, 2020 | 6.293B |
| December 31, 2019 | 5.755B |
| September 30, 2019 | 5.131B |
| June 30, 2019 | 5.487B |
| March 31, 2019 | 4.864B |
| December 31, 2018 | 4.020B |
| September 30, 2018 | 4.900B |
| June 30, 2018 | 4.639B |
| March 31, 2018 | 4.488B |
| December 31, 2017 | 2.930B |
| September 30, 2017 | 2.848B |
| June 30, 2017 | 2.811B |
| March 31, 2017 | 2.707B |
| December 31, 2016 | 2.587B |
| September 30, 2016 | 2.703B |
| June 30, 2016 | 2.615B |
| March 31, 2016 | 2.544B |
| December 31, 2015 | 2.491B |
| September 30, 2015 | 2.430B |
| June 30, 2015 | 2.358B |
| March 31, 2015 | 2.199B |
| December 31, 2014 | 2.185B |
| September 30, 2014 | 2.177B |
| June 30, 2014 | 2.250B |
| March 31, 2014 | 2.233B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 52.68B |
| Agilent Technologies, Inc. | 7.122B |
| Danaher Corp. | 52.58B |
| Illumina, Inc. | 2.838B |
| Revvity, Inc. | 7.229B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.25B |
| Total Liabilities (Quarterly) | 3.078B |
| Debt to Equity Ratio | 0.191 |
| Current Ratio | 3.142 |
| Net Debt Paydown Yield | -0.00% |